Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

Members of the DQSA Coalition and 39 State Pharmacy Associations Show Strong Support for HR 2871

Wednesday, July 26, 2017   (0 Comments)
Posted by: Dagmar Anderson
Share |


 

 

 

 

 

 

For Immediate Release: July 26, 2017

 

Contact: Dagmar Anderson, IACP VP Communications; 281.933.8400; dagmar@iacprx.org

 

 

Members of the DQSA Coalition and 39 State Pharmacy Associations Show Strong Support for Bipartisan Legislation, HR 2871, The Preserving Patient Access to Compounded Medications Act

 

WASHINGTON DC - The DQSA Coalition, a broad cross-section of organizations representing varied healthcare providers, state pharmacy associations, pharmacists and patients, sent a letter of support today to U.S. Representatives Morgan Griffith (VA) and Henry Cuellar (TX), Sponsors of HR 2871, The Preserving Patient Access to Compounded Medications Act.

 

From the letter - "The undersigned organizations represent patient advocates, physicians, pharmacists and other healthcare providers who are united in a mission to preserve patient safety and patient access to compounded medications. Since 2014, our organizations have been meeting and working together as part of a coalition ("the DQSA Coalition") to provide input to the FDA, to State Boards of Pharmacy and to the Congress about our concerns with FDA's implementation and enforcement of the Drug Quality and Security Act of 2013 ("DQSA", P.L. 113-54) and to seek solutions and policies that better balance patient safety with access to compounded medications.

"The DQSA Coalition strongly supports H.R. 2871, The Preserving Patient Access to Compounded Medications Act, and we urge the Congress to pass this important legislation as soon as possible. H.R. 2871 will clarify key provisions of the Food, Drug and Cosmetic Act (FDCA) as amended by the DQSA that the FDA has been misinterpreting in a way that has jeopardized access to compounded medications for the patients that need them."

 

This important bill will help protect access to compounded medications upon which patients rely. It will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and better balance public safety and patient access.

 

As such, it’s vital that Congress support HR 2871 in order to preserve patient access to compounded medications by directing FDA to act within Congressional intent.

 

About the International Academy of Compounding Pharmacists

 

The International Academy of Compounding Pharmacists (IACP) is an association representing nearly 4,000 pharmacists, technicians, students, and members of the compounding community who focus upon the specialty practice of pharmacy compounding.

 

IACP was instrumental in creating the DQSA Coalition and has led this broad provider and pharmacy organization with a primary goal of ensuring the FDA implements the Drug Quality & Security Act as Congress fully intended in order to preserve patient access to vital compounded medications.

 

 

# # #


Association Management Software Powered by YourMembership  ::  Legal